DCF — GUTHRIE CORTLAND MEDICAL CENTER
Enterprise Value: $-150.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-150.7M
Enterprise Value
$-48.4M
PV of Cash Flows
$-102.3M
PV of Terminal Value
$-164.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $115.8M | $-9.0M | -8.0% | $-13.9M | $-12.6M |
| Year 2 | $119.3M | $-8.1M | -7.0% | $-13.1M | $-10.8M |
| Year 3 | $122.9M | $-7.1M | -6.0% | $-12.3M | $-9.2M |
| Year 4 | $126.6M | $-6.7M | -5.0% | $-12.0M | $-8.2M |
| Year 5 | $130.4M | $-6.5M | -5.0% | $-12.1M | $-7.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-150.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$112.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0826145070979175
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5